European consortium awarded €6.5M to study psychedelic-assisted therapy

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

EU access to oncology medicines lags behind in the Netherlands – Pharmaceutical Technology

Share this article Takeda’s (Japan) Zejula (niraparib) was one of among six innovative anti-cancer medicines across 20 indications that were considered in this study. Credit:

January 17, 2024

COVID Vax Myocarditis Stays Mild With Good Prognosis Over a Year Later

People with postvaccine myocarditis did not share the typical mid-term complications associated with conventional myocarditis, based on a population-based study from France. With 18-month follow-up

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

European consortium awarded €6.5M to study psychedelic-assisted therapy

EU access to oncology medicines lags behind in the Netherlands – Pharmaceutical Technology

Progress and challenges in completing the human gene catalogue

COVID Vax Myocarditis Stays Mild With Good Prognosis Over a Year Later

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe